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WHAT THIS PAPER ADDS
 Although many reports have proven the efﬁcacy and safety of endovascular therapy (EVT) for critical limb ischaemia (CLI) in each
arterial segment, few reports have supported the general effectiveness of EVT in patients with CLI due to isolated below-the-knee
(BTK) lesions. Therefore, the purpose of this study was to investigate the total effectiveness of EVT on three long-term outcomes,
namely overall survival (OS), freedom from major amputation (MA) and reintervention, in patients with CLI due to isolated BTK
lesions, and to subsequently risk stratify each of these ‘end’ points.
 From our results, despite both high mortality and high reintervention rates, freedom fromMAwas acceptable after EVT for patients
with CLI presenting with isolated BTK lesions. Risk stratiﬁcation on outcomes plays an important role not only in estimating their
future occurrence, but also in deciding which revascularisation strategy to pursue for patients with CLI due to isolated BTK lesions.a r t i c l e i n f o
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Objectives: To assess and risk stratify midterm clinical outcomes after endovascular therapy (EVT) by
angioplasty only of patientswith critical limb ischaemia (CLI) due to isolated below-the-knee (BTK) lesions.
Design: Retrospective multicenter study.
Materials and methods: Between March 2004 and October 2010, 465 limbs (Rutherford 5 and 6: 79%)
from 406 patients were studied. Overall survival, limb salvage, and re-intervention were examined out to
3 years by the KaplaneMeier method and the log-rank test. Their independent predictors and risk
stratiﬁcation were analysed.
Results: Patient age was 71  11 yrs, with 69% diabetics and 60% on dialysis. Mean follow-up was 18  15
months. Overall survival was 76  2 and 57  4% at 1 and 3, years, respectively. Survival predictors were
body mass index <18, non-ambulatory status and ejection fraction <45%. Two-year limb salvage rate was
80 2%. Factors associatedwithmajor amputationwere ulcers (Rutherford 6), diabetesmellitus, C-reactive
protein>5mg/dL, and age< 60 years. Two-year freedom from re-interventionwas 66 3%; age and below-
the-ankle runoff number after angioplasty was negatively associated with re-intervention.
Conclusions: Despite relatively high mortality and re-intervention rates, limb salvage rate was acceptable
after EVT for CLI patients with isolated BTK lesions. Risk stratiﬁcation allows occurrence estimation for
each end point.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.: þ81 6 6419 1870.
ciety for Vascular Surgery. PublisheThe primary goals of the revascularisation by surgical bypass
therapy (BSX) or endovascular therapy (EVT) in patients with critical
limb ischaemia (CLI) are to relieve ischaemic pain, heal ischaemic
ulcers, prevent, limb loss and improve patient function andquality ofd by Elsevier Ltd. All rights reserved.
O. Iida et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 313e321314life.1,2 Patients with CLI, especially thosewith diabetesmellitus (DM)
and end-stage renal disease (ESRD) on dialysis, commonly present
with long, diffuse arteriosclerotic disease in the BTK region, which is
still considered best treated with saphenous vein graft BSX as ﬁrst-
line therapy.3,4 However, these patients are often not suitable
surgical candidates due to concomitant disease and advanced age,
making EVT preferable. On the other hand, thus far there are no
physiological data on risk stratiﬁcation for clinical outcomes after
EVT of patients with CLI due to isolated BTK lesion. While many
reports have proven the efﬁcacy and safety of EVT for CLI in each
arterial segment,5,6 few reports have supported EVT effectiveness in
patients with CLI due to isolated BTK lesions. Moreover, there is
a potential advantage for a simple adopted score for patientswith CLI
and isolated BTK lesions to predict patients/lesions less suitable for
endovascular treatment and thosewhomight beneﬁt themost from
this treatment. Therefore, this study investigated and risk-stratiﬁed
EVT midterm outcomes: namely, overall survival, limb salvage, and
re-intervention, in patients with CLI due to isolated BTK lesions.
Methods
Patients
We retrospectively analysed a prospectively maintained multi-
centre database from April 2004 to October 2010. The databaseTable 1
Baseline patient and lower limb characteristics in overall group, and comparison of thos
Variables as % (n) Overall (n ¼ 406)
Patients status
Age, years 71  11
Male gender 67% (274)
BMI 22  3
BMI <18 14% (57)
Total protein (g/dL) 7.0  0.8
Albumin (g/dL) 3.4  0.6
Non-ambulatory 43% (175)
Risk factors
Hypertension 77% (314)
Dislipidemia 29% (117)
Diabetes mellitus 69% (280)
Current smoking 30% (121)
ESRD on dialysis 60% (242)
Red blood cell count (/ml) 355  80
Haemoglobin (g/dl) 11.0  1.8
Cardiovascular disease
Coronary artery disease 52% (210)
Heart disease 56% (226)
Aortic valve stenosis 7% (30)
Mitral regurgitation 10% (41)
Heart rate (bpm) 81  16
Heart rate >80 bpm 52% (211)
EF (%) 58  14
EF<45% 15% (61)
Cerebrovascular disease 29% (118)
COPD 3% (12)
Lower limb status
Rutherford classiﬁcation 5.0  0.6
ABI before angioplasty 0.76  0.27
ABI < 0.6 19% (72)
White blood cell count (/ml) 7600  3100
CRP level (mg/dl) 2.5  4.0 [1.0]
CRP >3 mg/dl 24% (98)
Medication
Cilostazol 58% (236)
Statine 20% (81)
Vessel calciﬁcation 62%
Number of below-the-knee runoff after angioplasty 1.6  0.9
Reintervention 24% (98)
Major amputation 15% (59)
Comparison between patients who were either alive or dead at the end of the follow-up
ABI: Ankle/Brachial Index; COPD: congestive obstructive pulmonary disease.excluded patients who were considered poor candidates for
endovascular or surgical revascularisation due to severe co-
morbidities and impairment at the functional (bedridden without
intractable rest pain), cognitive (dementia not requiring institu-
tionalisation) and/or social (no family or professional career) levels,
or who refused revascularisation. Although intervention was not
attempted in patients with functionally unsalvageable limbs, non-
ambulatory patients without cognitive and social problems were
treated with angioplasty for limb salvage taking into consideration
patient’s preference and family co-operation, and lack of control of
rest pain with anaesthetics. During this period, 1068 limbs in 900
consecutive CLI patients received EVT in one of six cardiovascular
centres in Japan. After excluding patients with CLI due to BTK
lesions combined with femoropopliteal (FP) lesions (47%, 498 limbs
in 395 patients) or with aorto-iliac FP lesions (10%, 105 limbs in 99
patients), or who presented with acute limb ischaemia requiring
emergent revascularisation or with functionally unsalvageable
limbs, the data set used for the study included 465 limbs from 406
consecutive patients who underwent angioplasty alone for de novo
BTK lesions, and who also gave consent to provide clinical follow-
up during the chronic phase. All patients were symptomatic
secondary to isolated BTK lesions (Rutherford categories 4e6) with
threatened limb loss. During this period, 355 CLI patients were
treated with crural bypass therapy by a vascular surgeon. Data on
patients who did not undergo revascularisation or who underwente between death and alive group.
Death (n ¼ 130) Alive (n ¼ 276) P value
72  9 70  12 0.16
68% (89) 67% (185) 0.77
21  4 22  3 0.0043
23% (30) 9% (27) 0.0002
6.9  0.8 7.0  0.8 0.67
3.3  0.6 3.5  0.5 0.0003
60% (78) 35% (97) <0.0001
79% (103) 76% (211) 0.53
22% (29) 32% (88) 0.06
65% (85) 71% (185) 0.28
33% (43) 28% (78) 0.32
72% (94) 54% (148) 0.0003
348  89/ 359  77 0.22/
10.7  1.9 11.1  1.8 0.0051
58% (76) 49% (134) 0.06
64% (83) 52% (143) 0.02
9% (12) 7% (18) 0.32
12% (16) 9% (25) 0.30
85  19 79  15 0.0008
65% (84) 46% (127) 0.0009
53  15 61  13 <0.0001
29% (38) 9% (23) <0.0001
39% (51) 24% (67) 0.002
4% (5) 3% (7) 0.51
5.2  0.6 4.9  0.6 <0.0001
0.71  0.28 0.79  0.27 0.03
29% (40) 15% (30) 0.0028
8000  3600 7300  2900 0.03
3.6  4.8 [1.5] 2.0  3.6 [0.8] 0.002
38% (40) 18% (50) <0.0001
57% (74) 59% (162) 0.73
16% (21) 22% (60) 0.19
72% (93) 58% (160) 0.0085
1.5  0.8 1.7  0.9 0.06
24% (31) 24% (67) 0.99
20% (26) 12% (33) 0.03
period. Data are presented as mean [median] or % (n).
O. Iida et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 313e321 315BSX were not systematically collected and analysed. The study
protocol was developed in accordance with the Declaration of
Helsinki, and approved by the ethics committee of each hospital.
This study was registered in the University Hospital Medical
Information Network Clinical Trial Registry (UMIN-CTR), whichwas
approved by the International Committee of Medical Journal
Editors (no. UMIN000004917, J-BEAT registry: Japanese BElow-the-
knee Artery Treatment registry). All patients gavewritten informed
consent prior to revascularisation.
Protocols
On admission, the femoral, popliteal, dorsalis pedis and poste-
rior tibial arteries were palpated, and the extent of tissue loss was
recorded as part of the preoperative vascular study. We measured
the ankleebrachial index (ABI) and the skin perfusion pressure
(SPP) to assess the haemodynamic status of lower limb ischaemia.
SPP was generally measured on the dorsal and plantar sides of the
foot. In the SPP test, which uses a laser Doppler instrument
(PAD3000; Väsamed, Inc, Eden Prairie, MN, USA) to quantitatively
evaluate microcirculatory perfusion in the skin, a laser Doppler
sensor (NRL Laboratory for Structural Acoustics, LSA) is located
beneath a pressure cuff for application and release of pressure to
the limb. Lower limb arteries were routinely evaluated by duplex
ultrasound. All patients also underwent digital subtraction angi-
ography (DSA) before the procedure. Because 95% of patients (387/
405) had The Inter-Society Consensus for Management of PAD
(TASC) D lesions in a BTK artery, indication for endovascular
therapy was decided by consensus among vascular specialists
(including vascular surgeons, interventional cardiologists and
radiologists) depending on general condition and lower limb
severity. BSX was also selected by consensus among vascular
specialists.
All EVT procedures were performed under local anaesthesia by
cardiovascular interventionalists. EVT was indicated when the
lesion showed >75% diameter stenosis on DSA. Selection of EVTFigure 1. Overall survival for 406 patients with critical limb ischaemia due to isolated
below the knee lesion (BTK) undergoing angioplasty. An overall survival was 76% and
57% in the intention-to-treat (ITT) group and 76% and 58% in by-treated-actually (BTA)
analysis at 1 and 3 years, respectively.approach was left to the operator’s discretion. Generally, a 4-Fr
sheath was used for the antegrade approach from the ipsilateral
common femoral artery. After inserting the sheath, unfractionated
heparin (5000 units) was routinely injected into the artery. A
0.014-inch guide wire was advanced into the culprit lesion and an
optimal size of balloon catheter was introduced. The appropriate
balloon diameter was visually assessed. A 100-mm or 120-mm
balloon was used except in patients with short focal lesions.
Balloon inﬂation with pressures ranging from 4 to 12 atmwas held
for at least 180 s. Stent and atherectomy devices were not approved
for use in BTK intervention in Japan. We generally attempted
angiosome-based intervention of the target lesion. If treatment of
the angiosome-based target lesion did not result in successful
recanalisation, treatment of a non-angiosome-based lesion was
attempted to achieve one straight-line ﬂow to the ulcer. Dual anti-
platelet therapy (aspirin at 100 mg day1 and ticlopidine at
200 mg day1 or cilostazol at 200 mg day1) was started at least 1
week prior to EVT and continued lifelong.
Follow-up and outcomes
All patients were followed up at 1 week, 1, 3 and 6 months after
revascularisation, and thereafter every 3 months. If a patient did
not come to the hospital, telephone calls were made to check limb
status and the patient’s general health. All patients with open
ulcers were individually followed up by a plastic surgeon. Severity
of wounds, especially of those involving infection, was carefully
assessed by a plastic surgeon who decided the indication for anti-
biotic therapy and amputation timing. Ulcer status and time until
complete healing were recorded. Ulcer healing was deﬁned on the
basis of the ‘TIME’ (Tissue, Infection or Inﬂammation, Moisture
imbalance and Edge of wound (non-advancing or undermined))
concept, a clinical tool to evaluate emerging technologies inwound
management and wound assessment. SPP was measured before
and after the EVT procedure.
Deﬁnitions
Ischaemic tissue loss was deﬁned in accordance with TASC as
tissue loss associated with an ankle pressure <70 mmHg or a toe
pressure <50 mmHg. When these measurements could not be
obtained due to intractable rest pain or a non-compressible artery
because of severe calciﬁcation, SPP was measured at the dorsal and
plantar sides of the foot. An SPP <40 mmHg was deﬁned as indi-
cating ischaemic tissue loss.7 Atherosclerosis risk factors have beenFigure 2. Cause of death after angioplasty for patients with critical limb ischaemia due
to isolated below the knee lesions during 5 years, death occurred in 32% (130/406) of
patients. Approximately half (51%: 66/130) died due to cardiovascular disease and 27%
(35/130) died due to infectious disease.
Table 2
Multivariate Cox proportional hazard regression analysis for overall survival.
95% CI Hazard
ratio
P value
Body mass index<18 1.258e5.698 2.677 0.0109
Albumin (g/dl) 0.555e1.668 0.962 0.8901
Non-ambulatory 1.003e3.020 1.741 0.0487
Diabetes mellitus 0.527e1.718 0.952 0.8699
ESRD on dialysis 0.822e2.919 1.549 0.1733
Haemoglobin (g/dl) 0.819e1.153 0.972 0.7433
Heart rate > 80 bpm 0.811e2.397 1.394 0.2291
Ejection fraction < 45% 1.893e8.062 3.907 0.0002
Cerebrovascular disease 0.970e2.941 1.689 0.0649
Rutherford classiﬁcation 0.741e2.069 1.238 0.4143
ABI < 0.6 0.857e2.977 1.597 0.1433
Antibiotic therapy 0.607e2.560 1.247 0.5492
CRP level 0.946e1.104 1.022 0.5744
Vessel calciﬁcation 0.518e1.970 1.010 0.9761
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ular ﬁltration rate (GFR) < 60 l min1 1.73 m2. Coronary artery
disease (CAD) was deﬁned as history of any revascularisation of the
coronary arteries. Cerebrovascular disease (CVD) was deﬁned as
a history of stroke and/or cerebral haemorrhage. Non-ambulatory
status was deﬁned as wheelchair bound or bedridden status. EVT
procedural success was deﬁned as obtaining one straight-line ﬂow
to the ulcer or gangrene region without occurrence of any ﬂow
limiting dissection. EVT with angioplasty was considered haemo-
dynamically successful when postprocedural SPP level increased
more than 40 mmHg, which indicated high limb salvage rate. Re-
intervention included repeat angioplasty or bypass graft proce-
dures. Major amputation included all above and below the knee
cases. Survival dates were obtained from outpatient clinic follow-
up contact.Figure 3. Overall survival according to risk scores based on the multivariable logistic analys
88  3 and 84  3%, moderate-risk group: 75  4 and 60  5%, high-risk group: 44  7 anStudy ‘end’ points
Study ‘end’ points were overall survival, limb salvage and re-
intervention during the 5 years following the index procedure.
These were suggested as objective performance goals for eval-
uating catheter-based therapies in CLI by the Society of Vascular
Surgery (SVS).9 Complete follow-up was available for all
patients.
Statistical analysis
Continuous variables with or without normal distributions
were compared between groups using either the unpaired t-test
or ManneWhitney U test, respectively. Variables with a normal
distribution were expressed as mean values  SD, while median
and interquartile range was used for asymmetrically distributed
data (namely C-reactive protein (CRP) level). Chi-square test was
used to compare proportions between groups. Statistical signiﬁ-
cance level was set at p < 0.05. Independent outcome determi-
nants were identiﬁed by the Cox proportional hazard ratio in
multivariable analysis including all variables from univariable
analysis with a p-value of <0.01. We conducted risk stratiﬁcation
analysis for each ‘end’ point using a simpler score based on the
number of variables independently associated with each ‘end’
point in multivariable analysis. Each outcome was estimated
using the KaplaneMeier method and compared using the log-
rank test. In addition, patients in whom BTK angioplasty was
attempted were analysed as intention-to-treat (ITT) and those in
whom successful recanalisation with angioplasty was achieved
were analysed on a by-treated-actually (BTA) basis for each ‘end’
point. Statistical analyses were performed using the Statistical
Package for Social Sciences (SPSS) (SPSS Inc., Chicago, IL, USA)
software.is overall survival rate was lower in higher score groups (1 and 2 years: low-risk group:
d 27  7%, respectively; p < 0.001).
Table 3
Comparison of lower limb characteristics between major amputation and limb salvage groups.
Variables Overall (n ¼ 465) Major amputation
(n ¼ 69)
Limb salvage
(n ¼ 396)
P value
Patients status
Age, years 70  11 66  13 71  10 <0.0001
Age < 60 16% (75) 33% (23) 13% (52) <0.0001
Male, gender 68% (316) 73% (50) 67% (266) 0.38
BMI 22  3 22  3 22  3 0.87
Total protein (g/dl) 7.0  0.8 6.9  0.7 7.1  0.9 0.04
Albumin (g/dl) 3.4  0.6 3.2  0.5 3.4  0.6 0.0068
Non-ambulatory 43% (199) 58% (40) 40% (159) 0.0054
Risk factors
Hypertension 79% (363) 72% (50) 79% (313) 0.22
Hyperlipidaemia 30% (141) 28% (19) 31% (122) 0.58
Diabetes mellitus 70% (327) 86% (59) 68% (268) 0.0028
HbA1c 6.3  1.5 6.8  1.6 6.3  1.5 0.02
Current smoking 29% (136) 41% (28) 27% (108) 0.02
ESRD on dialysis 61% (283) 72% (50) 59% (233) 0.03
Red blood cell count (/ul) 356  79 346  74 358  80 0.26
Haemoglobin (g/dl) 11.0  1.8 10.7  1.8 11.0  1.8 0.13
Cardiovascular disease
CAD 52% (240) 61% (42) 50% (198) 0.10
Heart disease 57% (263) 64% (44) 55% (219) 0.19
EF (%) 57  15 58  14 57  15 0.76
CVD 29% (135) 28% (19) 29% (116) 0.78
COPD 3% (12) 0% (0) 3% (12) 0.14
Lower limb status
Rutherford classiﬁcation <0.0001
4 21% (96) 4% (3) 24% (93)
5 58% (270) 51% (35) 59% (235)
6 21% (99) 45% (31) 17% (68)
ABPI before angioplasty 0.78  0.25 0.77  0.31 0.78  0.24 0.60
Skin perfusion pressure before angioplasty 34  17 32  17 35  18 0.25
White blood cell count (/ul) 7600  3100 9300  3800 7300  2900 <0.0001
CRP level (mg/dl) 2.6  4.0 [1.0] 5.0  5.1 [3.3] 2.2  3.6 [0.8] <0.0001
CRP >5 mg/dl 16% (75) 38% (26) 13% (49) <0.0001
Medication
Cilostazol 58% (270) 46% (32) 60% (238) 0.03
Statine 21% (99) 22% (15) 21% (84) 0.92
Lesion severity
Vessel calciﬁcation 64% (297) 71% (49) 63% (248) 0.17
TASC D lesion (TASC 2000 classiﬁcation) 97% (445) 97% (67) 95% (378) 0.75
Treated lesion length (mm) 170  92 177  92 169  92 0.45
Diseased artery before/after angioplasty
Anterior tibial artery 91% (425)/39% (183) 91% (63)/42% (29) 91% (362)/39% (154) 0.99/0.23
Posterior tibial artery 89% (415)/60% (277) 91% (63)/70% (48) 89% (352)/58% (229) 0.55/0.07
Peroneal artery 75% (350)/44% (206) 75% (52)/55% (38) 75% (298)/43% (168) 0.98/0.05
Dorsalis pedis artery 51% (238)/40% (185) 59% (41)/48% (33) 50% (197)/38% (152) 0.14/0.15
Plantar artery 61% (283)/53% (248) 64% (44)/62% (43) 61% (239)/52% (205) 0.62/0.12
Number of below-the-knee (BTK) runoff after angioplasty 1.6  0.8 1.4  0.8 1.7  0.8 0.03
Number of below-the-ankle (BA) run-offs after angioplasty 1.1  0.7 0.9  0.7 1.1  0.7 0.02
Reintervention 29% (135) 41% (28) 27% (107) 0.02
Data are presented as mean, median for CRP level or % (n).
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Overall patient characteristics are shown in Table 1. There were
no signiﬁcant differences in overall patient characteristics
including atherosclerosis risk factors except for proportion of end-
stage renal disease (ESRD) patients on dialysis. Body mass index
(BMI) and albumin level were lower in the death group than in the
alive group. Non-ambulatory patients were more frequently
observed in the death group. Patients who died had worse lower
limb status at baseline, and a higher incidence of vessel calciﬁca-
tion, major amputation, heart disease, CVD and left-ventricular
ejection fraction (EF). Accordingly, white blood cell (WBC) and
CRP levels were higher in the death than in the alive group.
Thirty-day mortality following EVT was 2% (9/406). Procedural
success, deﬁned as obtaining one straight-line ﬂow to the ulcer or
gangrene region, was obtained in 94% (437/465) of the limbs and
36% (10/28) of these consequently proceeded to BSX conversion.Mean follow-up length was 18  15 months and overall survival
(Fig. 1) was 76% and 57% in the ITT group and 76% and 58% in BTA
analysis at 1 and 3 years, respectively. Fig. 2 shows distribution of
death causes. Approximately half the patients (51%: 66/130) died
from cardiovascular disease, including myocardial infarction, heart
failure or fatal arrhythmia. Cardiac death was the most frequent
cause of death (40%: 52/130) in these CLI patients. In 27% (35/130),
the cause of death was attributed to infectious disease.
Results of multivariable Cox proportional hazard regression
analysis of overall survival are shown in Table 2. BMI < 18 kg m2
(hazard ratio (HR), 2.7; 95% conﬁdence interval (CI), 1.3e5.5,
p ¼ 0.009), non-ambulatory status (HR, 1.9; 95% CI, 1.1e3.2,
p ¼ 0.02), and EF < 45% (HR, 3.7; 95% CI, 1.8e7.4, p ¼ 0.0003) were
positively associated with overall survival. Fig. 3 shows the strati-
ﬁcation of patient survival by number of risk factors after multi-
variate analysis. The sum of number of risk factors was then used to
calculate the risk score for each patient for subsequent
Figure 4. Limb salvage rate after angioplasty for 465 critical ischaemic limbs limb
salvage rate was 84% and 80% in the ITT group and 84% and 81% in the BTA group at 1
and 3 years, respectively. Almost all major amputations were performed before 1 year.
Table 4
Multivariate Cox proportional hazard regression analysis for major amputation.
95% CI Hazard
ratio
P value
Rutherford 6 1.228e4.387 2.321 0.0095
Non-ambulatory 0.827e2.648 1.480 0.1863
Presence of diabetes mellitus 1.100e4.792 2.296 0.0269
Alb (g/dl) 0.513e1.513 0.088 0.6462
CRP > 5 mg/dl 1.251e5.341 2.585 0.0103
Age <60 1.427e5.294 2.749 0.0025
White blood cell count (/ml) 0.937e1.136 1.032 0.5203
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risk, n ¼ 181), 1 (moderate-risk, n ¼ 170) and 2e3 (high-risk,
n ¼ 55); patients were followed up for up to 3 years. The survival
rate was lower in the higher risk groups (1- and 2-year rates: low-
risk, 88% and 84%; moderate-risk, 75% and 60%; and high-risk, 44%
and 27%, respectively; p < 0.001).Figure 5. Limb salvage rate according to the risk scores based on the multivariable logisti
97  2; moderate-risk group, 86  2; and high-risk group: 44  8 and 44  8%, respectiveLower limb status is shown in Table 3. Younger and non-
ambulatory patients were more frequently observed in the major
amputation group. Total protein and albumin levels were lower
while DM, ESRD on dialysis and current smoking were more
prevalent in the major amputation group. Unlike predictors of
overall survival, each co-morbidity had no effect on limb salvage.
Lower limb status and level of inﬂammation were worse in the
major amputation group. Cilostazol was more frequently adminis-
tered in the limb salvage group. A higher number of BTK runoff
vessels was more frequently obtained and the incidence of re-
intervention was signiﬁcantly lower in the limb salvage group.
Three-year limb salvage rate is shown in Fig. 4; it was 84% and
80% in the ITT group and 84% and 81% in the BTA group at 1 and 3
years, respectively. After multivariate analysis, Rutherford 6 ulcers,
presence of DM, CRP >5 and age <60 years were signiﬁcant
predictors of major amputation (Table 4). Risk stratiﬁcation of
major amputation is shown in Fig. 5. A similar methodology was
used for subsequent categorisation into three groups: number of
risk factors: 0 (low-risk, n ¼ 93), 1e2 (moderate-risk, n ¼ 327) and
3e4 (high-risk, n ¼ 45), respectively; patients were followed up for
a year. The rate of limb salvagewas lower in the higher score groupsc analysis limb salvage rate was lower in higher score groups (1 year: low-risk group,
ly; p < 0.001).
O. Iida et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 313e321 319(1 year: low-risk, 97%; moderate-risk, 86%; and high-risk, 44%,
respectively; p < 0.001).
Comparison of characteristics between the re-intervention and
the no-re-intervention group is shown in Table 5. There were no
signiﬁcant differences in atherosclerosis risk factors except for
proportion of patients with ESRD on dialysis and younger patients
being more frequent in the re-intervention versus the no-re-
intervention group. A TASC D lesion was seen in 97% (445/465) of
patients, while calciﬁcationwas present in 64% (297/465) of lesions.
The presence of vessel calciﬁcation was more prevalent in the re-
intervention group. The number of below-the-ankle (BA) runoffs
after angioplasty affected the subsequent re-intervention rate.
Freedom from re-interventionwas 72% and 66% in the ITT group
and 73% and 68% in the BTA group at 1 and 2 years, respectively
(Fig. 6). During the chronic phase, 7% (33/465) of limbs underwent
surgical conversion after initial EVT. Variables number of BA runoff
and age were negatively associated with re-intervention (Table 6).
The presence of less BA runoff vessels at the end of procedure was
related to higher re-intervention rate in the overall cohort (Fig. 7).Table 5
Comparison of characteristics between re-intervention and no-reintervention group.
Overall (n ¼ 465)
Patients status
Age, years 70  11
Male, gender 68% (316)
BMI 22  3
Total protein (g/dl) 7.0  0.8
Albumin (g/dl) 3.4  0.6
Non-ambulatory 43% (199)
Risk factors
Hypertension 79% (363)
Dislipidemia 30% (141)
Diabetes mellitus 70% (327)
HbA1c 6.3  1.5
Current smoking 29% (136)
ESRD on dialysis 61% (283)
Red blood cell count (/ul) 356  79/
Haemoglobin (g/dl) 11.0  1.8
Cardiovascular disease
CAD (Coronary Artery Disease) 52% (240)
EF 57  15
CVD 29% (135)
COPD 3% (12)
Lower limb status
Rutherford classiﬁcation
4 21% (96)
5 58% (270)
6 21% (99)
ABI before angioplasty 0.78  0.25
White blood cell count (/ul) 7600  3100/
CRP (mg/dl) 2.6  4.0 [1.0]
Medication
Cilostazol 58% (270)
Statine 21% (99)
Lesion severity
Vessel calciﬁcation 64% (297)
TASC D lesion (TASC 2000 classiﬁcation) 97% (445)
Treated lesion length (mm) 170  92
Treated lesion pre % stenosis 98  5
Treated lesion post % stenosis 32  27
Diseased artery after angioplasty
Anterior tibial artery 39% (183)
Posterior tibial artery 60% (277)
Peroneal artery 44% (206)
Dorsalis pedis artery 40% (185)
Plantar artery 53% (248)
Number of below-the-knee run-offs after angioplasty 1.6  0.8
Number of below-the-ankle run-offs after angioplasty 1.1  0.7
Major amputation 15% (69)
Data are presented as mean, median for CRP level or % (n).Discussion
Three-year overall survival, limb salvage and re-intervention
rates were 57%, 79% and 61%, respectively. BMI < 18 kg m2, non-
ambulatory status and EF <45% were predictors of overall
survival. Rutherford 6 ulcers/gangrene, presence of DM, CRP level
>5 mg dl1 and age <60 years were positively associated with
major amputation. Age and number of BTK runoffs after angioplasty
were negatively associated with re-intervention. In the setting of
CLI due to isolated BTK lesions, risk stratifying these outcomes
allows us to estimate future event occurrence for each ‘end’ point.
The role of EVT in treating CLI remains controversial. Hence, BSX
has been considered as the primary treatment modality for CLI
because of high haemodynamic success and graft durability.1,2
Although in the randomised BASIL (Bypass versus angioplasty in
severe ischaemia of the leg) trial decision of which revascularisation
strategy to pursue, BSX or EVT, was based on the presence of usable
vein and life expectancy,10,11 over the past decade CLI treatment
strategy has been rapidly changing. Many new technologies haveReintervention
(n ¼ 139)
No-reintervention
(n ¼ 326)
P value
68  10 72  11 0.0001
71% (98) 67% (218) 0.59
22  3 22  3 0.77
7.0  0.8 6.9  0.8 0.31
3.4  0.6 3.4  0.6 0.87
37% (52) 45% (147) 0.15
78% (109) 78% (254) 0.99
30% (42) 30% (99) 0.99
73% (101) 69% (226) 0.51
6.3  1.2 6.4  1.7 0.43
32% (44) 28% (92) 0.50
72% (100) 56% (183) 0.0013
358  72 355  83 0.79
11.0  1.7 11.0  1.9 0.92
58% (80) 49% (160) 0.10
57  16 58  14 0.48
28% (39) 29% (96) 0.82
2% (3) 3% (9) 0.77
0.15
16% (22) 23% (75)
59% (82) 58% (189)/
25% (35) 19% (62)
0.75  0.25 0.80  0.25 0.09
7500  2900 7600  3200 0.84
2.3  3.6 [1.2] 2.7  4.2 [0.9] 0.29
53% (74) 60% (196) 0.18
20% (28) 22% (71) 0.80
73% (102) 60% (195) 0.0060
99% (137) 95% (308) 0.05
178  95 167  90 0.22
98  5 98  6 0.93
36  29 30  26 0.06
43% (60) 38% (123) 0.30
65% (90) 57% (187) 0.15
43% (60) 45% (146) 0.70
44% (61) 38% (124) 0.26
63% (87) 49% (161) 0.0081
1.5  0.8 1.6  0.8 0.18
0.9  0.6 1.1  0.7 0.0032
21% (28) 12% (41) 0.03
Figure 6. Freedom from re-intervention. Freedom from re-intervention was 72% and
66% in the ITT group and 73% and 68% in the BTA group at 1 and 2 years, respectively at
1 and 2 years, respectively.
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between 1999 and 2004, when patients with severe limb ischaemia
participated in the BASIL trial. These new technologies have
dramatically enhanced treatment strategy options for CLI patients,
and have subsequently expanded the overall indication.12 EVT with
traditional angioplasty is most widely used in the BTK region
because it achieves acceptable limb salvage when compared with
BSX.13 Treating BTK critical limb ischaemia with drug-eluting stents
has also emerged as an effective and safe means of relieving
symptoms and preventing major amputation while maintaining
a low procedural complication rate.14
The 1-year overall survival in this study was 75%, similar to that
of un-reconstructed CLI patients in the TASC II guidelines. In this
study, 69% of patients had DM, 60% had ESRD on dialysis, 44% of
patients had non-ambulatory status and approximately half
(score > 0: 55%) had risk factors for survival. Inclusion of these
patients probably led to a similar survival rate as TASC II.2 In terms
of factors associated with overall survival, low EF and non-
ambulatory status are easily recognised in patients who had
poorer outcomes during the chronic phase. That an active lifestyle
reduces the risk of cardiovascular disease and consequently has
a beneﬁcial effect on mortality in a healthy elderly population is
well known.15 Non-ambulatory CLI patients could not perform
sufﬁcient exercise to prolong longevity ultimately leading to poorer
outcomes as compared with ambulatory CLI patients. BMI <18 kg
m2 was a novel predictor for overall survival in CLI patients.
Interestingly, patients with peripheral artery disease who were
obese or overweight showed a better survival rate than patients
with normal weight, which has been termed the obesity paradox.16Table 6
Multivariate Cox proportional hazard regression analysis for re-intervention.
95% CI Hazard ratio P value
Age 0.954e0.992 0.973 0.006
ESRD on dialysis 0.851e2.359 1.417 0.18
Vessel calciﬁcation 0.805e2.219 1.337 0.26
Below-the-ankle (BA) runoff after EVT 0.486e0.913 0.666 0.01Therefore, this survival score is in good agreement with general
consensus regarding CLI patients. To the best of our knowledge, this
is the ﬁrst report on risk stratiﬁcation for overall survival in the
context of angioplasty in CLI patients due to isolated BTK lesions.
In our study the 5-year limb salvage rate was 79%, which is
comparable with 70e80% at 5 years reported in a series of BSX
patients.17 Seven major amputation-related variables were exam-
ined and four independent factors (Rutherford 6 ulcers/gangrene,
CRP> 5mgdl1, DMand age< 60 years)were shown to affectmajor
amputation after multivariable analysis. Except for age <60 years,
these factors were comparable to the predictors for major ampu-
tation seen in earlier studies.2 It is commonly recognised that amore
severe state of the limb, especially Rutherford 6 ulcer/gangrene,
more likely results in a higher major amputation rate. The need for
major amputation is twofold higher in patients with ulcers or
gangrene than in patients with only rest pain.1 It was reported in
TASC II that the rate of major amputation in DM patients was 5e10
times higher than that in patientswithout DMbecause the presence
of DM appears to reduce blood ﬂow to the microvascular bed via
arteriovenous ﬁstulae.1,18 In this study, high CRP levels implied the
presence of infection in the lower limb, which has been widely re-
ported to increase the demand for blood ﬂow to the microvascular
bed consequently resulting in a higher major amputation rate.18
Contrary to recently published data, younger patients showed
higher major amputation rate. The major amputation rate in
patients <60 years old was 31% during the 5-year period of this
study. We performed an additional analysis comparing the back-
ground characteristics of patients over 60 years and less than 60
years old. As a result we found that DM and dialysis, both of which
strongly affect major amputation rate, were more prevalent in
patients aged less than 60 years than in patients over 60 years old
(DM: 80% vs. 68%, dialysis 81% vs. 57%). Younger CLI patients also
had more advanced atherosclerosis and more severe BTK arteryFigure 7. Reintervention rate according to the number of below the ankle (BA) arteries
less BA runoff vessels at the end of procedure was related to higher re-intervention
rate in the chronic phase (BA 2 vs. BA 1: p ¼ 0.0013, BA 2 vs. BA 0: p ¼ 0.0021, BA1
vs. BA 0: p ¼ 0.74).
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after angioplasty.
Factors associated with re-intervention were age and less ﬁnal
BA runoffs after angioplasty. Younger patients showed a higher re-
intervention rate because of similar major amputation aetiology.
Final BA runoff was a novel predictor of re-intervention after BTK
angioplasty. The BA artery is connected to the distal BTK artery as
an outﬂow vessel. In addition, factors negatively affecting the
patency of aorto-iliac and FP revascularisation include quality of
BTK runoff vessels in TASC II. Therefore, we consider that BA runoff
plays an important role as outﬂow vessel affecting vessel patency
after BTK angioplasty.
Limitations
This was a retrospective and non-randomised study despite use
of a prospectively maintained database. Patients considered
unsuitable for revascularisation or treated with bypass therapy
were not managed by the physicians involved in the study and
therefore data on themwere not collected and analysed. Device use
was limited to traditional balloon angioplasty, which was the only
option available in Japan at the time of this study. In addition,
healing time and ulcer severity details, particularly wound size and
depth, were not evaluated by Texas or Wegner classiﬁcation
because this study was retrospective. Lack of uniformity in terms of
medical therapy could represent a relevant source of bias in the
study. Finally, we could not assess primary patency of treated
BTK lesions because they were typically long and calciﬁed,
rendering difﬁcult their precise assessment by Duplex. Therefore,
re-intervention rate was evaluated instead of patency.
The midterm clinical efﬁcacy of EVT has not yet been system-
atically studied in patients with CLI due to isolated BTK artery
lesions. Therefore, the results of this study help inform selection of
revascularisation strategy for patients with CLI due to isolated BTK
lesions; indication for angioplasty for this patient population
should be strictly followed in the clinical setting because of the high
mortality and re-intervention rates. The long-term clinical efﬁcacy
of next-generation devices for BTK intervention warrants further
investigation.
Conclusion
Despite both high mortality and high re-intervention rates, limb
salvage was acceptable after EVT for CLI patients with isolated BTK
lesions. Risk stratiﬁcation on outcomes plays an important role in
estimating future occurrence of each ‘end’ point in patients with CLI
due to isolated BTK lesions.
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